#USA #Nashville #OneOncology #Radiation Oncology #Todd Doyle

OneOncology Welcomes Dr. Todd Doyle

In a significant move to bolster community-based cancer care, OneOncology has appointed Dr. Todd Doyle, a respected leader in radiation oncology, as its new Chief of Radiation Oncology (CRO). This strategic appointment was officially announced on September 23, 2025, marking an important step in OneOncology's mission to support independent medical specialty practices across the United States.

Dr. Doyle is not new to the field of radiation oncology; he has substantial experience serving as a practicing radiation oncologist and is the President of New York Oncology Hematology. This partnership brings together a robust team of over 60 healthcare providers dedicated to delivering high-quality cancer care in the Albany region. Dr. Doyle will utilize his extensive knowledge to lead the growth and implementation of innovative strategies in radiation oncology and advanced medical imaging, ensuring that OneOncology remains at the forefront of cancer treatment innovation.

Being named CRO, Dr. Doyle will focus on developing a comprehensive growth strategy aimed at enhancing clinical excellence across OneOncology partner practices and affiliates of the United Urology Group (UUG). "The role of the CRO is to provide expertise and support that enables OneOncology and UUG partner practices to lead the country in the delivery of community-based radiation oncology and advanced imaging," stated Dr. Doyle. His commitment to excellence suggests promising directions for cancer care, as he looks forward to collaborating with various practice partners within the OneOncology and UUG network.

Dr. Doyle will play a pivotal role in guiding partner practices on the best clinical strategies to enhance the oncology services they provide. Additionally, he will oversee the integration of value-based care models and technological advancements into their programs. This progressive approach indicates a commitment to improving patient outcomes and ensuring that care remains accessible within local communities.

Davey Daniel, MD, Chief Medical Officer of OneOncology, praised Dr. Doyle's impressive background saying, "Dr. Doyle is a nationally respected leader who has spent more than 20 years practicing in the independent setting and advising practices nationwide on radiation oncology initiatives. His knowledge and passion for excellence will be invaluable to our network and partner practices."

Dr. Doyle joins a highly esteemed Clinical Affairs physician leadership team, including other prominent figures in oncology. Jeff Patton, MD, CEO of OneOncology, emphasized the importance of exceptional physicians in leadership, stating, "Bringing exceptional physicians like Dr. Doyle into leadership roles ensures OneOncology stays laser-focused on clinical excellence." This approach is vital in reshaping public perceptions of independent medical practices, highlighting that modern, innovative care can be effectively delivered in community settings.

Founded on the premise of improving lives through community oncology, OneOncology was developed by community physicians with the goal of allowing medical practices to maintain their independence while also enhancing patient access to quality care. The organization serves a nationwide network comprising approximately 1,800 providers and manages care for roughly one million patients across 565 locations. By providing essential support including group purchasing and clinical innovation, OneOncology aims to improve the operational efficiency of partner practices while reducing healthcare costs.

With his extensive expertise and a clear vision for the future of radiation oncology, Dr. Doyle’s contributions are expected to advance how cancer care is delivered within the community. This appointment signifies OneOncology’s ongoing dedication to fostering collaborative environments where independent practices thrive and patients receive the highest standard of care without needing to resort to hospital settings for innovative treatment options.

To learn more about OneOncology and its initiatives, visit oneoncology.com or connect via their LinkedIn profile.